Related Experiment Video
Updated: Nov 17, 2025
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Neonatal Retinoblastoma
Frank Y Lin1, Murali M Chintagumpala1
1Texas Children's Cancer Center, Baylor College of Medicine, 6701 Fannin Street, Suite 1510, Houston, TX 77030, USA.
Insights
Retinoblastoma, a rare childhood eye cancer, requires early detection for best outcomes. Understanding at-risk infants is crucial for timely screening and treatment, improving survival and vision salvage.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Genetics
Background:
- Retinoblastoma is the most frequent eye cancer in children.
- It affects approximately 300 children annually in the U.S. and is considered rare.
- While common in young children, neonatal diagnosis is infrequent, highlighting the need for risk assessment.
Purpose of the Study:
- To emphasize the importance of identifying at-risk infants for retinoblastoma.
- To underscore the critical role of early detection and multidisciplinary care.
- To highlight the significance of RB1 gene testing in management and counseling.
Main Methods:
- Review of current clinical practices and literature regarding retinoblastoma diagnosis and management.
- Emphasis on the standard practice of RB1 gene alteration testing.
- Focus on the multidisciplinary approach to treatment.
Main Results:
- Early detection and prompt treatment by a specialized team improve survival rates.
- Timely intervention maximizes the chances of ocular and vision salvage.
- Minimizing treatment toxicity is a key goal in management.
- RB1 gene testing is integral for informing screening and genetic counseling.
Conclusions:
- Identifying infants at risk for retinoblastoma is essential for targeted screening protocols.
- A multidisciplinary approach is vital for optimal patient outcomes.
- RB1 gene analysis plays a key role in personalized care and family guidance.
Abstract:
Retinoblastoma is the most common ocular malignancy of childhood. With an estimated 300 cases annually in the United States, retinoblastoma is nevertheless considered a rare tumor. Although retinoblastoma primarily affects younger children, diagnosis during the neonatal age range is less common. However, an understanding of patients at risk is critical for appropriate screening. Early detection and treatment by a multidisciplinary specialty team maximizes the chance for survival and ocular/vision salvage while minimizing treatment-related toxicity. Testing for alterations in the RB1 gene has become standard practice, and informs screening and genetic counseling recommendations for patients and their families.
More Related Videos
07:55Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
